FastCompany RSS

Topic: Celera Corporation

  
   |  Comment

The Gene Bubble: Why We Still Aren't Disease-Free

When the human genome was first sequenced nearly a decade ago, the world lit up with talk about how new gene-specific drugs would help us cheat death. Well, the verdict is in: Keep eating those greens.READ»

   |  Comment

The Age of Disruption

Still not convinced that there's much "new" about the new economy? Then spend some time with Harvard's Juan Enriquez. In his new book, and in an interview, he explains how business and economics are changing -- and what it means for you.READ»

   |  Comment

Health and the Profit Motive

Victoria Hale creates the country's first nonprofit pharmaceutical company.READ»

   |  Comment

Digital Matters - Issue 47

"Many things matter, and here's what matters most."READ»

   |  Comment

The Secret of Life

The mapping of the human genome, says Craig Venter, will change science, research, medicine, politics, health insurance, and the way biology looks at the last 3 billion years of evolution. And that's just the beginning.READ»

   |  Comment

Digital Matters - Issue 38

"We are nearing the end of tedious, dull and small politics."READ»

   |  Comment

Digital Matters - Issue 34

"A few years from now, we'll look back on dotcom mania as a model of investment sanity and prudence."READ»

   |  Comment

Digital Matters - Issue 29

In My Humble Opinion: Genomics is the most important economic, political, and ethical issue facing mankind.READ»

   |  Comment

Next Stop - The 21st Century

Unit of Twenty-OneREAD»